Transcriptome analysis reveals involvement of thiopurine S-methyltransferase in oxidation-reduction processes
Abstract:Thiopurine S-methyltransferase (TPMT) is an important enzyme involved in [...]
Xerna™ TME Panel is a machine learning-based transcriptomic biomarker designed to predict therapeutic response in multiple cancers
Abstract: Most predictive biomarkers approved for clinical use measure [...]
Pitfalls and Rewards of Setting Up a Liquid Biopsy Approach for the Detection of Driver Mutations in Circulating Tumor DNAs: Our Institutional Experience
Abstract: We describe our institutional experience of developing a [...]
Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Navicixizumab plus paclitaxel demonstrated promising clinical activity in bevacizumab-treated and -naive patients with platinum-resistant ovarian cancer, with manageable toxicity.
